• Leading brokers name 3 ASX shares to buy today

    Buy ASX shares

    With so many shares to choose from on the Australian share market, it can be hard to decide which ones to buy.

    The good news is that brokers across the country are doing a lot of the hard work for you.

    Three top shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

    Audinate Group Ltd (ASX: AD8)

    According to a note out of UBS, its analysts have retained their buy rating but cut the price target on this media networking technology company’s shares to $7.30. The broker is a big fan of Audinate’s Dante product and believes it has a massive long term market opportunity. And while it does expect sales to soften over the coming quarters due to the pandemic, the broker believes it is well worth looking beyond this and focusing on its long term potential. I agree with UBS and feel Audinate would be a great buy and hold option for investors.

    REA Group Limited (ASX: REA)

    A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $105.00 price target on this property listings company’s shares. It was pleased with its latest quarterly update given the tough trading conditions it was facing. And while conditions in the industry continue to be tough, the broker remains positive on its long term prospects. Especially given the structural tailwinds it is benefiting from. I agree with Morgan Stanley and feel REA Group is a top blue chip to own.

    Reject Shop Ltd (ASX: TRS)

    Analysts at Goldman Sachs have upgraded this discount retailer’s shares to a buy rating from sell and put a price target of $4.75 on them. Goldman likes Reject Shop due to its turnaround story with a new executive team, a more robust balance sheet, and the potential for material improvements in efficiencies in labour, rent and stock turn. It also notes that its valuation is supported by a cash balance that was 28% of its market capitalisation based on its last closing price. While I’m not a big fan of Reject Shop, I think Goldman Sachs makes some very good points.

    And here are five dirt cheap shares which analysts have just given buy ratings to as well.

    NEW! 5 Cheap Stocks With Massive Upside Potential

    Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

    One is a diversified conglomerate trading 40% off it’s all time high, all while offering a fully franked dividend yield of over 3%…

    Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

    Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

    Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

    But you will have to hurry because the cheap share prices on offer today might not last for long.

    YES! SEND ME THE FREE REPORT!

    Returns as of 7/4/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. The Motley Fool Australia has recommended REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Leading brokers name 3 ASX shares to buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3dtRfbu

  • ASX stock of the day: This ASX materials share jumped 11% today on a 250% surge in profits

    The Advance Nanotek Ltd (ASX: ANO) share price has surged 11.51% today after the company announced profits are expected to more than double. Net profit before tax for FY20 is expected to be approximately $8.4 million, 2.5 times greater than FY19 profit before tax. 

    What does Advance Nanotek do?

    Advance Nanotek manufactures zinc oxide, which is used in sunscreen. First formed in 1997, Advance Nanotek has been listed on the ASX since 2003. Its product range suits a wide variety of sunscreens and cosmetics, with its Zinxation recipe providing SPF50+ for broad UVA/UVB protection. Advance Nanotek has a current annual capacity of 3,000 tonnes, and is investing to increase capacity beyond 5,000 tonnes. 

    Advance Nanotek’s business

    Around 70% of Advance Nanotek’s sales are in the US. The company’s production facilities were temporarily closed in the US but have now reopened with sunscreen manufacturing recommenced, albeit at smaller volumes. Advance Nanotek expects US sales volumes to return to normal and has established stockpiles in a logistics facility to take advantage of the expected upturn in conditions. 

    The board is looking to expand Advance Nanotek’s aluminium oxide business into new markets and improve supply to existing customers by raising capacity. Stock will be made available at an EU logistics facility, with sales from the aluminium oxide product in FY20 expected to be ~$2 million. 

    Financial results

    Advance Nanotek recorded sales revenue of $11.3 million in 1HFY20, up from $4.7 million in 1HFY19. Net profit before tax for the half was $4.81 million, nearly 3 times greater than the prior corresponding period. Earnings per share increased to 5.71 cents up from 3.03 cents in 1HFY19. 

    The company ended the half with cash and cash equivalents of $304,964 and borrowings of $1.1 million. Strong sales continued into the second half with profit before tax of $1.3 million in January. FY20 anticipated turnover is up 46% on FY19 to $18 million. 

    Outlook

    US sales increased 280% for the 7 months to 31 January over the prior corresponding period. Some negative impact from coronavirus has been experienced with US citizens cancelling or delaying travel plans for the summer. This may have a modest negative impact on Advance Nanotek’s $30 million FY20 sales target. 

    Nonetheless, Advance Nanotek has seen impressive increases in profit over the last few years. Profit before tax increased from $0.56 million in the 5 months to November 2017 to $3.831 million in the 5 months to November 2019. Full year FY20 net profit is estimated to be $8.4 million. 

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off it’s high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    As of 7/4/2020

    More reading

    Kate O’Brien has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Advance NanoTek Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post ASX stock of the day: This ASX materials share jumped 11% today on a 250% surge in profits appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2LeyblJ

  • Elon Musk Talks About The Tesla Cybertruck Smash-Up: ‘I Was Not Expecting That’

    Elon Musk Talks About The Tesla Cybertruck Smash-Up: 'I Was Not Expecting That'Tesla (NASDAQ: TSLA) CEO Elon Musk opened up to Joe Rogan in a podcast last week, about the Cybertruck smash-up last year.When Musk presented the Cybertruck, a much-anticipated all-electric pickup, it didn't quite go as planned.Musk showed off the strength of the new Cybertruck by having its door beaten with a sledgehammer and the window glass struck with heavy metal balls — and the glass cracked. 'I Was Not Expecting That,' Musk Says "What was it like when the dude threw the steel balls at the window and it broke?" Rogan asked Musk. "You know our demos are authentic!" the CEO replied."I was not expecting that and I mumbled under my breath 'holy sh–' — I swore and didn't think the mic would pick it. We practiced this behind the scenes … at Tesla we don't do tons of practice with our car demos because we are working on the cars and building new technologies. We are not doing hundreds of practice things … we don't have time for that."Just hours before the demo, Musk and his chief designer Franz von Holzhausen were throwing steel balls at the windows and they were bouncing right off, Musk told Rogan."We think what happened was when Franz hit the door with the sledgehammer — we think that he cracked the corner of the glass at the bottom, and once you crack the coroner of the glass, then it's game over," Musk said. Tesla's stock closed Friday at $819.42 per share. The stock has a 52-week high of $968.99 and a 52-week low of $176.99.Related Links:Elon Musk Talks Neuralink, Brain Stimulation And AI With Joe RoganElon Musk Says Tesla's Stock Price Is Too High, Tweets About Freedom, Gene Wilder And MoreScreenshot via The Guardian on YouTube. See more from Benzinga * Elon Musk Talks Baby X Æ A-12, Selling Possessions * Elon Musk Says Coronavirus A 'Trial Run' For Future Pandemic, Questions Mortality Rate * Elon Musk Talks Neuralink, Brain Stimulation And AI With Joe Rogan(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/3fC1tsn